Update meta-analysis on the efficacy and safety issues of fexofenadine

Update meta-analysis on the efficacy and safety issues of fexofenadine

Background: Fexofenadine emerged as one of the most representative second generation histamine H1 antagonist drugs since the 1990s, with an outstanding efficacy and appreciable safety for the treatment of allergic patients. While allergic rhino-conjunctivitis represents the most frequent atopic dise...

Full description

Bibliographic Details
Main Authors: René Maximiliano Gómez, MD, PhD, Pablo Moreno, MD, Enrico Compalati, MD, PhD, Giorgio Walter Canonica, MD, PhD, Ignacio Javier Ansotegui Zubeldia, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:World Allergy Organization Journal
Subjects:
Histamine H1 antagonist
Non sedating
Safety
Efficacy
Fexofenadine
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123000558

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123000558

Similar Items